These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals. Saenghirunvattana S J Med Assoc Thai; 1996 May; 79(5):285-7. PubMed ID: 8708519 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients. Lui SL; Li FK; Choy BY; Chan TM; Lo WK; Lai KN Transpl Infect Dis; 2004 Mar; 6(1):55-6. PubMed ID: 15225230 [No Abstract] [Full Text] [Related]
17. [Human immunodeficiency virus infection and tuberculosis: who should receive chemoprophylaxis?]. Moreno Guillén S Rev Clin Esp; 1994 Feb; 194(2):73-4. PubMed ID: 8008942 [No Abstract] [Full Text] [Related]
18. [Experimental basis and practical possibility of application in man of the new method of antituberculous chemoprophylaxis by means of isoniazid]. OMODEI-ZORINI A Minerva Med; 1956 Dec; 47(101):2158-68. PubMed ID: 13399936 [No Abstract] [Full Text] [Related]
19. [Modern views on the chemoprophylaxis of tuberculosis and a proposal for modifications and additions to legal and expert reporting documents]. Cavić L Plucne Bolesti; 1984; 36(3-4):252-7. PubMed ID: 6533652 [No Abstract] [Full Text] [Related]
20. [Are microbiological studies necessary before starting tuberculosis chemoprophylaxis?]. Barrasa Villar JI; Guimbao Bescós J; Gotor Lázaro G; Aspíroz Sancho C Med Clin (Barc); 1995 Oct; 105(14):559. PubMed ID: 8523937 [No Abstract] [Full Text] [Related] [Next] [New Search]